A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study

PURPOSE: Data on the efficacy of olanzapine in patients receiving moderately emetogenic chemotherapy (MEC) are limited. This study aimed to evaluate and compare the efficacy of olanzapine versus placebo in controlling nausea and vomiting in patients receiving MEC. MATERIALS AND METHODS: We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, So-Yeon, Han, Hye Sook, Bae, Woo Kyun, Park, Moo-Rim, Shim, Hyeok, Lee, Sang-Cheol, Go, Se-Il, Yun, Hwan Jung, Im, Yong-Jin, Song, Eun-Kee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333980/
https://www.ncbi.nlm.nih.gov/pubmed/29510613
http://dx.doi.org/10.4143/crt.2017.577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333980/
https://www.ncbi.nlm.nih.gov/pubmed/29510613
http://dx.doi.org/10.4143/crt.2017.577

Ejemplares similares